Atlas Trials

Observational Study of Glucose Tolerance Abnormalities in Patient With Cystic Fibrosis Homozygous for Phe 508 Del CFTR Treated by Lumacaftor-Ivacaftor

Clinical trial NCT03512119 · COMPLETED

Trial details

NCT number
NCT03512119
Sponsor
University Hospital, Strasbourg, France
Status
COMPLETED
Study type
OBSERVATIONAL
Cystic Fibrosis Homozygous for Phe 508 Del CFTRGlucose Intolerance or Newly Diagnosis Diabetes
Start date
2016-02-11
Primary completion
2019-04-10
Enrollment
55

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.